Lisa Massmanian
Geen lopende functies
Profiel
Lisa Massmanian formerly worked at Curis, Inc., as Director-Clinical Operations, ImmunoGen, Inc., as Research Associate, and Merrimack Pharmaceuticals, Inc., as Manager-Clinical Operations.
Ms. Massmanian received her graduate degree from Northeastern University.
Eerdere bekende functies van Lisa Massmanian
| Bedrijven | Functie | Einde |
|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
| IMMUNOGEN, INC. | Corporate Officer/Principal | - |
| CURIS, INC. | Operationeel Directeur | - |
Opleiding van Lisa Massmanian
| Northeastern University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CURIS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
